Abstract
Purpose
Caffeine, a nonselective antagonist of adenosine receptors, is the most popular psychostimulant worldwide. Recently, a protective role of moderate chronic caffeine consumption against neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease has been discussed. Thus, aim of the present study was an in vivo investigation of effects of long-term caffeine consumption on the adenosine A1 receptor (A1AR) in the rat brain.
Procedures
Sixteen adult, male rats underwent five positron emission tomography (PET) scans with the highly selective A1AR radioligand [18F]CPFPX in order to determine A1AR availability. After the first baseline PET scan, the animals were assigned to two groups: Caffeine treatment and control group. The caffeine-treated animals received caffeinated tap water (30 mg/kg bodyweight/day, corresponding to 4–5 cups of coffee per day in humans) for 12 weeks. Subsequently, caffeine was withdrawn and repeated PET measurements were performed on day 1, 2, 4, and 7 of caffeine withdrawal. The control animals were measured according to the same time schedule.
Results
At day 1, after 4.4 h of caffeine withdrawal, a significant decrease (− 34.5%, p < 0.001) of whole brain A1AR availability was observed. Unlike all other investigated brain regions in caffeine-treated rats, the hypothalamus and nucleus accumbens showed no significant intraindividual differences between baseline and first withdrawal PET scan. After approximately 27 h of caffeine withdrawal, the region- and group-specific effects disappeared and A1AR availability settled around baseline.
Conclusions
The present study provides evidence that chronic caffeine consumption does not lead to persistent changes in functional availability of cerebral A1ARs which have previously been associated with neuroprotective effects of caffeine. The acute and region-specific decrease in cerebral A1AR availability directly after caffeine withdrawal is most likely caused by residual amounts of caffeine metabolites disguising an unchanged A1AR expression at this early time-point.
Similar content being viewed by others
References
Fredholm BB, Ijzerman AP, Jacobson KA et al (2001) International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53:527–552
Fastbom J, Pazos A, Palacios JM (1987) The distribution of adenosine A1 receptors and 5′-nucleotidase in the brain of some commonly used experimental animals. Neuroscience 22:813–826
Fastbom J, Pazos A, Probst A et al (1987) Adenosine A1 receptors in the human brain: a quantitative autoradiographic study. Neuroscience 22:827–839
Gessi S, Merighi S, Varani K et al (2011) Adenosine receptors in health and disease. Adv Pharamacol 61:41–75
Paul S, Elsinga HP, Ishiwata K et al (2016) Adenosine A(1) receptors in the central nervous system: their functions in health and disease, and possible elucidation by PET imaging. Curr Med Chem 18:4820–4835
Holschbach MH, Olsson RA, Bier D et al (2002) Synthesis and evaluation of no-carrier-added 8-cyclopentyl-3-(3-[18F]fluoropropyl)-1-propylxanthine ([18F]CPFPX): a potent and selective A1-adenosine receptor antagonist for in Vivo imaging. J Med Chem 45:5150–5156
Elmenhorst D, Kroll T, Wedekind F et al (2013) In vivo kinetic and steady-state quantification of [18F]-CPFPX binding to rat cerebral A1 adenosine receptors: validation by displacement and autoradiographic experiments. J Nucl Med 54:1–9
Bauer A, Holschbach MH, Meyer PT et al (2003) In vivo imaging of adenosine A1 receptors in the human brain with [18F]CPFPX and positron emission tomography. NeuroImage 19:1760–1769
Fredholm BB, Bättig K, Holmén J et al (1999) Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 51:83–133
Nehlig A, Daval JL, Debry G (1992) Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Res Brain Res Rev 17:139–170
Addicott MA, Laurienti PJ (2009) A comparison of the effects of caffeine following abstinence and normal caffeine use. Psychopharmacology 207:423–431
James JE, Rogers PJ (2005) Effects of caffeine on performance and mood: withdrawal reversal is the most plausible explanation. Psychopharmacology 182:1–8
Eskelinen MH, Ngandu T, Toumilehto J et al (2009) Midlife coffee and tea drinking and the risk of late-life dementia: a population-based CAIDE study. J Alzheimers Dis 16:85–91
Qi H, Li S (2014) Dose-response meta-analysis on coffee, tea and caffeine consumption with risk of Parkinson’s disease. Geriatr Gerontol Int 14:430–439
Dunwiddie TV, Masino SA (2001) The role and regulation of adenosine in the central nervous system. Annu Rev Neurosci 24:31–55
Boulenger G, Marangos PJ (1989) Caffeine withdrawal affects central adenosine receptors but not benzodiazepine receptors. J Neural Transm Gen Sect 78:9–15
Daval JL, Deckert J, Weiss SR et al (1989) Upregulation of adenosine A1 receptors and forskolin binding sites following chronic treatment with caffeine or carbamazepine: a quantitative autoradiographic study. Epilepsia 30:26–33
Ramkumar V, Bumgarner JR, Jacobson KA et al (1988) Multiple components of the A1 adenosine receptor-adenylate cyclase system are regulated in rat cerebral cortex by chronic caffeine ingestion. J Clin Invest 82:242–247
Espinosa J, Rocha A, Nunes F et al (2013) Caffeine consumption prevents memory impairment, neuronal damage, and adenosine A2A receptors upregulation in the hippocampus of a rat model of sporadic dementia. J Alzheimers Dis 34:509–518
Georgiev V, Johansson B, Fredholm BB (1993) Long-term caffeine treatment leads to a decreased susceptibility to NMDA-induced clonic seizures in mice without changes in adenosine A1 receptor number. Brain Res 612:271–277
Johansson B, Georgiev V, Kuosmanen T et al (1996) Long-term treatment with some methylxanthines decreases the susceptibility to bicuculline- and pentylenetetrazol-induced seizures in mice. Relationship to c-ios expression and receptor binding. Eur J Neurosci 8:2447–2458
Marangos PJ, Boulenger G, Patel J (1984) Effects of chronic caffeine on brain adenosine receptors: regional and ontogenetic studies. Life Sci 34:899–907
Boulenger G, Patel J, Post RM et al (1983) Chronic caffeine consumption increases the number of brain adenosine receptors. Life Sci 32:1135–1142
Sengupta P (2013) The laboratory rat: relating its age with human’s. Int J Prev Med 4:624–630
Elmenhorst D, Meyer PT, Matusch A et al (2012) Caffeine occupancy of human cerebral A1 adenosine receptors: in vivo quantification with [18F]-CPFPX and PET. J Nucl Med 53:1723–1729
Kaplan GB, Greenblatt DJ, Kent MA et al (1993) Caffeine treatment and withdrawal in mice: relationships between dosage, concentrations, locomotor activity and A1 adenosine receptor binding. J Pharamcol Exp Ther 266:1563–1572
Kroll T, Elmenhorst D, Weisshaupt A et al (2014) Reproducibility of non-invasive A1 adenosine receptor quantification in the rat brain using [18F]CPFPX and positron emission tomography. Mol Imag Biol 16:699–709
Innis RB, Cunningham VJ, Delforge J et al (2007) Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab 27:1533–1539
Lammertsma AA, Hume SP (1996) Simplified reference tissue model for PET receptor studies. NeuroImage 4:153–158
Shukitt-Hale B, Miller MG, Chu YF et al (2013) Coffee, but not caffeine, has positive effects on cognition and psychomotor behavior in aging. Age (Dordr) 35:2183–2192
Wu PH, Coffin VL (1984) Up-regulation of brain [3H]diazepam binding sites in chronic caffeine-treated rats. Brain Res 294:186–189
Bonati M, Latini R, Galletti F et al (1982) Caffeine disposition after oral doses. Clin Pharmacol Ther 32:98–106
Bortolotti A, Traina GL, Guaitani A et al (1990) In vivo and perfused liver caffeine kinetics in the rat. Res Commun Chem Pathol Pharmacol 69:285–295
Liu X, Smith BJ, Chen C et al (2005) Use of a physiologically based pharmacokinetic model to study the time to reach brain equilibrium: an experimental analysis of the role of blood-brain barrier permeability, plasma protein binding, and brain tissue binding. J Pharmacol Exp Ther 313:1254–1262
Wang Y, Lau CE (1998) Caffeine has similar pharmacokinetics and behavioral effects via the i.p. and p.o. routes of administration. Pharmacol Biochem Behav 60:271–278
Daly JW, Butts-Lamb P, Padgett W (1983) Subclasses of adenosine receptors in the central nervous system: interaction with caffeine and related methylxanthines. Cell Mol Neurobiol 3:69–80
Gasior M, Jaszyna M, Munzar P et al (2002) Caffeine potentiates the discriminative-stimulus effects of nicotine in rats. Psychopharmacology 162:385–395
Liu X, Smith BJ, Chen C et al (2006) Evaluation of cerebrospinal fluid concentration and plasma free concentration as a surrogate measurement for brain free concentration. Drug Metab Dispos 34:1443–1447
Hawkins M, Dugich MM, Porter NM et al (1988) Effects of chronic administration of caffeine on adenosine A1 and A2 receptors in rat brain. Brain Res Bull 21:479–482
Elmenhorst D, Meyer PT, Matusch A et al (2007) Test-retest stability of cerebral A1 adenosine receptor quantification using [18F]CPFPX and PET. Eur J of Nucl Med Mol Imaging 34:1061–1070
Green RM, Stiles GL (1986) Chronic caffeine ingestion sensitizes the A1 adenosine receptor-adenylate cyclase system in rat cerebral cortex. J Clin Invest 77:222–227
Acknowledgments
Tim Urbansky, Andrea Radermacher, Sylvia Köhler-Dibowski, Stefanie Krause, and Dorothe Krug are gratefully acknowledged for excellent technical assistance. We thank Daniela Schneider for analyzing plasma caffeine concentrations, Nikola Kornadt-Beck for fruitful discussions and valuable support, and Johannes Ermert and Bernd Neumaier for radioligand supply.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
All experiments were approved by the regional authorities and conducted in accordance with the German Animal Protection Act.
Conflict of Interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Nabbi-Schroeter, D., Elmenhorst, D., Oskamp, A. et al. Effects of Long-Term Caffeine Consumption on the Adenosine A1 Receptor in the Rat Brain: an In Vivo PET Study with [18F]CPFPX. Mol Imaging Biol 20, 284–291 (2018). https://doi.org/10.1007/s11307-017-1116-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11307-017-1116-4